Back to Journals » OncoTargets and Therapy » Volume 10

Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant

Total article views   HTML views PDF downloads Totals
10,836 Dovepress* 9,240+ 1,302 10,542
PubMed Central* 1,596 277 1,873
Totals 10,836 1,579 12,415
*Since 21 August 2017
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar